Evidence map›Paper›PMID 41986235›Full record

ArticleLife science alliance2026

Scalable workflows for high-throughput respirometry.

Corey A Osto, Eugene V Mosharov, Ayelet M Rosenberg, Martin Picard, Linsey Stiles, Orian Shirihai

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Corey A OstoDepartment of Medicine, Endocrinology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0009-0007-5622-7393
Eugene V MosharovDepartment of Psychiatry, Divisions of Molecular Therapeutics and Behavioral Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Ayelet M RosenbergDepartment of Psychiatry, Divisions of Molecular Therapeutics and Behavioral Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Martin PicardDepartment of Psychiatry, Divisions of Molecular Therapeutics and Behavioral Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Linsey StilesDepartment of Medicine, Endocrinology, University of California, Los Angeles, Los Angeles, CA, USA.
Orian ShirihaiDepartment of Medicine, Endocrinology, University of California, Los Angeles, Los Angeles, CA, USA oshirihai@mednet.ucla.edu.ORCID 0000-0001-8466-3431

Funding

Patient-specific iPSCs to model and treat the inception of pulmonary fibrosisP01HL170952 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2024 to 2026
$11.4M
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancerR01CA208642 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI David B Shackelford · 2016 to 2026
$3.9M
PE methylation in skeletal muscle energy efficiencyR01DK107397 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI FUNAI, KATSUHIKO · 2017 to 2025
$3.8M
The impact of HSP72 on mitochondrial function and muscle metabolismR01DK078760 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Andrea L Hevener · 2009 to 2026
$2.8M
Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)R01DK141923 · NIDDK · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MARK W. GRINSTAFF, Orian S Shirihai · 2024 to 2026
$1.9M
The Role of Mitochondria in Dysregulated Insulin Secretion in ObesityR01DK144611 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Orian S Shirihai · 2025 to 2026
$1.3M
NCI NIH HHS R01 CA208642NHLBI NIH HHS P01 HL170952NIDDK NIH HHS R01 DK078760NIDDK NIH HHS R01 DK107397NIDDK NIH HHS R01 DK141923NIDDK NIH HHS R01 DK144611
6 · The paper itself

Abstract

Mitochondrial respirometry, the measurement of oxygen consumption rate (OCR) by the electron transport chain (ETC), is a cornerstone of mitochondrial biology and the gold standard for measurements of mitochondrial function. However, existing respirometry methodologies are poorly suited for large-scale studies and high-throughput applications, ultimately limiting the applicability of these methods. This limitation necessitates new methodologies, which are more easily scaled as mitochondrial studies become more complex and diverse. In this study, we detail a respirometry approach we have developed for high-throughput applications including optimized plate layouts, volume-based sample normalization, robust control selection, and automated data processing and quality control. Furthermore, we validate these methodologies across a respirometry study running 703 human brain samples, totaling more than 10,000 data points, which underwent our automated data processing and quality control techniques. Our workflow streamlines assay preparation, execution, and analysis to make respirometry scalable, while reducing operator burden and preserving data integrity. With this study, we provide a transferable blueprint for high-throughput respirometry as the mitochondrial biology field and the studies within it continue to expand in scale.

Indexed as

High-Throughput Screening AssaysMitochondriaOxygen ConsumptionBrainElectron TransportHumansWorkflow

Identifiers

PMID41986235
PMCPMC13084159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.